The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAukett Swanke Regulatory News (AUK)

Share Price Information for Aukett Swanke (AUK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.55
Bid: 1.40
Ask: 1.70
Change: 0.00 (0.00%)
Spread: 0.30 (21.429%)
Open: 1.55
High: 1.55
Low: 1.55
Prev. Close: 1.55
AUK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

26 Mar 2020 07:00

RNS Number : 6072H
Aukett Swanke Group PLC
26 March 2020
 

Embargoed for release until 0700 26 March 2020

Aukett Swanke Group Plc

AGM statement

At the Company's Annual General Meeting to be held today at 12pm, Nicholas Thompson (CEO) will make the following statement:

Following the spread of the Covid-19 virus the Company and its subsidiaries, joint ventures and Associates implemented their Business Continuity Plans in line with local procedures and relevant government protocols.

Primarily this involved a transfer of office operations to home or remote working. Trialling of home working had been on-going and, due to the uneven spread of the virus some geographies were able to manage this shift in working arrangements in advance of others. Our three largest offices in London, Berlin and Dubai are now fully set up for remote working with only limited staff present in offices in line with local protocols.

Our services are spread across three different activities: concept and pre planning; technical drawings up to tender; and site services and inspections. The first two activities have been largely unaffected by this transition at present. The feasibility of work on site needs to be addressed on a case by case basis to ensure operational capacity, though practical issues can be partially mitigated by off-site reporting and communication. With most sites currently open and, social distancing in place, construction projects continue in most jurisdictions. We are monitoring this activity on a daily basis.

The cost impact of these changes has, thus far, been minimal in terms of additional direct capital expenditure though it remains to be seen as to the efficiency with which we are still able to deliver services and the impact this may have. The Board will continue to monitor all aspects of customer service delivery and take whatever mitigating actions as are required.

The company operates a stringent cash management system across all operations and thus Group liquidity is good at this time; we expect to be able to continue to operate within current banking facilities. UK state support schemes are being looked into as a matter of urgency and will be implemented shortly, as required.

Clearly no business is immune to the wider effects of a pandemic but so far Aukett continues to function well and is as focussed as ever on supporting all stakeholders alike, customers, employees and suppliers.

We are grateful to our staff for their perseverance in maintaining client services whilst observing and following guidance on their self-protection and personal well-being.

Enquiries

 

Aukett Swanke Group Plc - 020 7843 3000

Nicholas Thompson, Chief Executive Officer

Antony Barkwith, Group Finance Director

 

finnCap - 020 7220 0500

Corporate Finance: Julian Blunt; Giles Rolls / Corporate Broking: Alice Lane

 

Investor/Media enquiries

 

Chris Steele 07979 604 687

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMKKPBNPBKDFNB
Date   Source Headline
4th Apr 20247:00 amRNSSubscription Update & Director/PDMR Notifications
28th Mar 202411:52 amRNSHolding(s) in Company
28th Mar 20247:00 amRNSFinal Results and Notice of AGM
27th Mar 202412:04 pmRNSHolding(s) in Company
27th Mar 202412:03 pmRNSHolding(s) in Company
21st Mar 20247:00 amRNSAcquisition, Subscription and Notice of Results
19th Feb 20247:00 amRNSArtificial Intelligence Consortium
14th Feb 202410:40 amRNSHolding(s) in Company
2nd Feb 20247:00 amRNSCommercial Update
4th Jan 20247:00 amRNSHolding(s) in Company
27th Dec 20237:00 amRNSLaunch of Employee Share Purchase Plans
17th Nov 20232:32 pmRNSHolding(s) in Company
14th Nov 20239:02 amRNSHolding(s) in Company
18th Oct 20237:00 amRNSAcquisition of TR Control Solutions Limited
10th Oct 202311:15 amRNSHolding(s) in Company
5th Oct 202312:01 pmRNSProperty marketed for sale
17th Jul 20237:00 amRNSAcquisition of Anders+Kern U.K. Limited
27th Jun 20237:05 amRNSAppointment of Chief Operating Officer
27th Jun 20237:00 amRNSInterim Results
27th Apr 20231:20 pmRNSHolding(s) in Company
24th Apr 20237:00 amRNSAppointment of Non-Executive Director
21st Apr 202311:45 amRNSResult of AGM and Board Changes
5th Apr 20233:15 pmRNSPosting of Notice of AGM and Annual Report
4th Apr 20237:00 amRNSDisposal of Live Events Business
28th Mar 20237:00 amRNSResults for the year ended 30 September 2022
21st Mar 20237:00 amRNSResult of GM, Board Change, Acquisition Completion
2nd Mar 20237:00 amRNSProposed Acquisition, Rule 9 Waiver and GM Notice
1st Feb 20234:53 pmRNSChange of Adviser
30th Jan 20234:37 pmRNSHolding(s) in Company
8th Dec 202212:40 pmRNSBoard Changes
17th Nov 20229:00 amRNSHolding(s) in Company
5th Oct 20223:15 pmRNSHolding(s) in Company
6th Sep 20227:00 amRNSHolding(s) in Company
2nd Sep 202211:20 amRNSHolding(s) in Company
16th Aug 20227:00 amRNSHolding(s) in Company
4th Aug 20223:27 pmRNSHolding(s) in Company
4th Aug 20223:24 pmRNSHolding(s) in Company
25th Jul 202210:53 amRNSCompletion of Nominated Adviser Due Diligence
29th Jun 20227:00 amRNSInterim Results
7th Jun 20226:00 pmRNSHolding(s) in Company
29th Apr 20227:00 amRNSSale of John R Harris & Partners Limited
29th Apr 20227:00 amRNSSale of John R Harris & Partners Limited
28th Apr 20227:00 amRNSAppointment of Nominated Adviser
26th Apr 20227:00 amRNSAnnouncement of results of AGM
11th Apr 20227:00 amRNSHolding(s) in Company
31st Mar 20227:00 amRNSAnnouncement of final results for the year end
28th Feb 20228:45 amRNSHolding(s) in Company
30th Jun 20217:00 amRNSGrant of Options to a director
29th Jun 20217:00 amRNSInterim results
29th Mar 20212:47 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.